6 DIFFERENT COUNTRIES:
France, Germany, Italy, UK, Canada and the US
Rosacea is a visible, inflammatory skin disease affecting around 415 million people worldwide and approximately 16 million people in the U.S.
Many people suffer from rosacea, but not everyone is willing to bring it up to their dermatologist in its earlier stages. Patients shouldn't have to settle with their symptoms and can be encouraged that clearance is a possibility with proper treatment and adherence.
It goes beyond what patients feel physically and varies greatly based on their personality. No matter their perception, no one should live with untreated rosacea. Identifying your patient's personality type and approach to rosacea can help navigate your treatment discussion.
Use this checklist to discuss rosacea symptoms with your patients, including symptoms beyond the visible.
A global survey** was conducted with the aim to gain a deeper understanding of the true extent of the burden of rosacea.
France, Germany, Italy, UK, Canada and the US
completed the survey
High burden patients report spending up to 3.5 hours more on their skin regimen per week.1** These patients are more likely to suffer from non-visible symptoms like1:
are ready to give up a year or more of their life to cure rosacea.1
said they had known little or nothing about signs and symptoms prior to their diagnosis.†
said their condition had lowered their self-confidence and self esteem.†
said the disorder had adversely affected their professional interactions.†
experience symptoms almost continuously.†
The symptoms of rosacea can go far beyond skin deep. As healthcare professionals, understanding the full spectrum of the disease is key to promoting better outcomes for everyone living with rosacea. By encouraging patients to talk about how the disease affects them emotionally, we can better assess the right approach to treatment.
It all starts with a doctor-patient-dialogue. Rosacea is a chronic disease, and patients often face the burden alone. Inviting them to discuss the true impact of rosacea allows patients to understand all their options and doctors to improve their knowledge and outcomes of the disease.
Ask questions that go beyond visible symptoms, like “have you had to miss days of work or school because of your skin condition? Do you feel stressed out, embarrassed or insecure because of your rosacea?”
Indication: Soolantra® (ivermectin) Cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. Adverse Events:
In clinical trials with Soolantra® Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation.
Warnings / Precautions: Not for oral, ophthalmic or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit WWW.FDA.GOV/MEDWATCH or call 1-800-FDA-1088.